PFKFB3 and Sepsis: Targeting dysregulated EC metabolism has recently (re)gained increased interest as a therapeutic strategy for sepsis (188, 189), and it is worth noting that several studies have shown beneficial effects of PFKFB3 inhibition in acute sepsis-induced lung injury models (190, 191).